In its 11th year, Pharmaceutical Formulation & Quality (PFQ) focuses on the unique niche of post-discovery development and validation, delivering a unique blend of content that no other pharmaceutical publication in the market offers. As part of the pharmaceutical publication portfolio of Wiley-Blackwell, the scientific, technical medical and scholarly business of John Wiley & Sons, Inc., PFQ offers a unique blend of pharmaceutical and biotechnological content from its sister publications, including journals, books, and Web offerings. PFQ also features original news articles distributed twice a month via the PFQ eNewsletter and a content-rich, easily navigable web site. PFQ provides an excellent blend of high-quality contributed and freelancer written articles.